In vivo absorbed dose measurements in mammography using a new real-time luminescence technique

British Journal of Radiology

Volumn 78, Issue 928, 2005, Pages 328-334

  Aznar, M C ^a   Hemdal, B ^b   Medin, J ^b   Marckmann, C J ^a   Andersen, C E ^a   Botter Jensen L ^a   Andersson, I ^b   Mattsson, S ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM OXIDE; CARBON;

ARTICLE; BODY SURFACE; CLINICAL EXAMINATION; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; IMAGE ANALYSIS; IMAGE QUALITY; IN VIVO STUDY; IONIZATION CHAMBER; LUMINESCENCE; MAMMOGRAPHY; RADIATION DOSE; RADIATION ENERGY; REPRODUCIBILITY; THERMOLUMINESCENCE; X RAY FILM;

ALUMINUM OXIDE; BREAST NEOPLASMS; FEMALE; FIBER OPTICS; HUMANS; MAMMOGRAPHY; RADIOTHERAPY DOSAGE; REPRODUCIBILITY OF RESULTS; THERMOLUMINESCENT DOSIMETRY;

EID: 17244376757     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/22554286     Document Type: Article

References (17)

1. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997;(22):63-7.
2. Dance DR. Monte Carlo calculation of conversion factors for the estimation of mean glandular breast dose. Phys Med Biol 1990;35:1211-9.
3. Zoetelief J, Fitzgerald M, Leitz W, Säbel M. European protocol on dosimetry in mammography. EUR 16263, 1996.
4. Dance DR, Skinner CL, Young KC, Beckett JR, Kotre CJ. Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol. Phys Med Biol 2000;45:3225-40.
5. van Engen R, Young K, Bosmans H, Thijssen M. Addendum on digital mammography, European Guidelines for Quality Assurance in Mammography Screening 2003 EUREF.
6. EURATOM. The European medical exposure directive 97/43. Council Directive 97/43/Euratom of 30 June 1997 on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, 1997.
7. Perry N, Broeders M, de Wolf C, Törnberg S, editors. European Guidelines for Quality Assurance in Mammography Screening (3rd edn). 2001 European Commission, EUREF.
8. Socialstyrelsen. National Board of Health and Welfare. Screening with Mammography for early Detection of Breast Cancer 1998. SoS-report 1998:17 (Stockholm, in Swedish).
9. SSI, Swedish Radiation Protection Authority, Regulations and general advice on diagnostic standard doses and reference levels within medical X-ray diagnostics, SSI FS 2002:2 (Stockholm, in Swedish, non-authorised translation to English is available at www.ssi.se), 2002.
10. Bøtter-Jensen L, McKeever SWS. Optically stimulated luminescence dosimetry using natural and synthetic materials. Radiat Prot Dosim 1996;65:273-80.
11. 3:C as a sensitive OSL dosemeter for rapid assessment of environmental photon dose rates. Radiat Meas 1997; 27:295-8.
12. Aznar MC, Andersen CE, Bøtter-Jensen L, Bäck SÅJ, Mattsson S, Kjær-Kristoffersen F, et al. Real-time optical-fibre luminescence dosimetry for radiotherapy: physical characteristics and applications in photon beams. Phys Med Biol 2004;49:1655-69.
13. Olsen JB, Sager EM. Subjective evaluation of image quality based on images obtained with a breast tissue phantom: comparison with a conventional image quality phantom. Br J Radiol 1995;68:160-4.
14. Burch A, Law J. A method for estimating compressed breast thickness during mammography. Br J Radiol 1995;68:394-9.
15. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976;121:545-52.
16. ICRU Stopping powers for electrons and positrons, ICRU Report 37, 1984.
17. Chan HP, Doi K. Monte Carlo simulation studies of backscatter factors in mammographyx. Radiology 1981;139: 195-9.